❌

Reading view

A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia

Nature Medicine, Published online: 31 March 2026; doi:10.1038/s41591-026-04303-y

ProtAIDe-Dx is a deep joint-learning model that uses plasma proteomics to provide simultaneous probabilistic diagnoses across six conditions associated with aging.
  •  

Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial

Nature Medicine, Published online: 31 March 2026; doi:10.1038/s41591-026-04315-8

Benralizumab (an anti-IL-5 receptor Ξ± antibody), compared to placebo, significantly reduced the risk of first flare in patients with hypereosinophilic syndrome.
  •  

An atlas to navigate environmental factors and health

Nature Medicine, Published online: 30 March 2026; doi:10.1038/s41591-026-04286-w

We have systematically mapped the exposome onto health and disease risk to replace pervasive fragmented research. Although exposure associations are modest, these reproducible patterns reflect how our surroundings can affect our bodies and collectively shape our health. Our atlas provides a blueprint for integrating and evaluating environmental factors into precision medicine.
  •  

How inadequate dietary patterns affect global burden of ischemic heart disease

Nature Medicine, Published online: 30 March 2026; doi:10.1038/s41591-026-04321-w

Despite major global declines in ischemic heart disease mortality, the influence of suboptimal diet remains substantial and unevenly distributed across populations. This study quantifies the contributions of individual dietary components to ischemic heart disease over more than 30 years and uncovers persistent disparities by age, sex, region and socioeconomic status.
  •  
❌